New York, NY -- (SBWIRE) -- 09/12/2014 -- Dementia is one of the serious brain disorders which lead to memory loss, language and thinking ability. Dementia is caused by death of brain cells. The most common forms of Dementia are Alzheimer's disease, vascular dementia, Lewy body dementia and frontotemporal dementia. Moreover, movement disorders are also neurological condition that affects the movement of the body. Movement disorders include several conditions, such as Huntington's disease, Parkinson's disease, Ataxia and Wilson disease.

The global market of treatments for syndromes of dementia is categorized on various drugs which are used in treatment of progressive dementia diseases, progressive dementia with other neurological diseases, movement disorder syndromes and by technological treatment. The progressive dementia disease segment is further sub-segmented into Alzheimer’s disease, Lewy body dementia and Pick’s disease. Alzheimer’s disease is one of the major forms of dementia, characterized by death of brain cells and leads to brain shrinking.

Browse Complete Report on Treatments for Syndromes of Dementia and Movement Disorders - Global Industry Analysis and Forecast to 2020 (http://www.persistencemarketresearch.com/market-research/treatment-syndromes-dementia-movement-disorders-market.asp)

The progressive dementia with other neurological disease segment is further sub-segmented into Huntington’s disease and corticobasal ganglionic degeneration. The movement disorders syndrome treatment drug segment includes Parkinson’s disease, multiple system atrophy, progressive supranuclear palsy and Hhallervorden-spatz disease. The technological treatment segment comprises small molecules based on therapies and monoclonal antibodies. Out of these segments, progressive dementia holds major share followed by dementia with other neurological diseases and movement disorders syndromes.

In terms of geography, the U.S. and Canada hold major market share of treatments for syndromes of dementia and movement disorders in North America. In Europe, Germany, France and the U.K are some of the major countries which are large markets of treatments for syndromes of dementia and weakness disorders in the region.

Globally, treatments for syndromes of dementia and movement disorders market is driven by increased R&D spending, rising awareness towards mental diseases and increasing prevalence of neurodegenerative diseases. Moreover, technological advancement for treatment of dementia and other movement disorders is also supporting the growth of the market. In addition, increased collaboration between pharmaceutical companies and research institutes to develop advanced drugs for syndromes of dementia and movement disorders is a key market trend.

Request Full Report With TOC:
http://www.persistencemarketresearch.com/samples/2833

However, lack of complete curative treatment for dementia and movement disorders is a key restraint for treatments for syndromes of dementia and movement disorders market.

Some of the major companies operating in the treatment for syndromes of dementia and movement disorders market are Abbott Laboratories, Accera Inc. Acorda Therapeutics Inc., Alliance Pharma PLC, Alzhyme Ltd., Baxter International Inc., Cadila Healthcare Ltd., Cellzome AG, Ranbaxy Laboratories Ltd., Roche Holding Ltd., Pfizer Inc., Novartis AG, Mylan Pharmaceuticals and Merck Serono.

Key points covered in the report:

1. Report segments the market on the basis of types, application, products, technology, etc (as applicable)

2. The report covers geographic segmentation

North America
Europe
Asia
RoW

3. The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020

4. The report provides company profiles of some of the leading companies operating in the market

For More Upcoming Reports Visit
http://www.persistencemarketresearch.com/forthcoming-reports.asp

About Persistence Market Research
Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services

At Persistence Market Research (PMR), we are in the business of accelerating your business. As a full-service market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability.

PMR’s Services Go Beyond Gleaning Data
Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.

Contact Us:
Addie Thomes
305 Broadway,
7th Floor,
New York City, NY 10007
United States
USA/Canada Toll Free Number
800-961-0353
E-mail: Sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com